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Magnetic forces enable controlled drug delivery
by disrupting endothelial cell-cell junctions
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The vascular endothelium presents a major transport barrier to drug delivery by only allowing
selective extravasation of solutes and small molecules. Therefore, enhancing drug transport
across the endothelial barrier has to rely on leaky vessels arising from disease states such as
pathological angiogenesis and inﬂammatory response. Here we show that the permeability of
vascular endothelium can be increased using an external magnetic ﬁeld to temporarily disrupt
endothelial adherens junctions through internalized iron oxide nanoparticles, activating the
paracellular transport pathway and facilitating the local extravasation of circulating
substances. This approach provides a physically controlled drug delivery method harnessing
the biology of endothelial adherens junction and opens a new avenue for drug delivery in a
broad range of biomedical research and therapeutic applications.
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T
he circulatory system provides an efﬁcient route for the
distribution of blood-borne substances throughout the
body. However, the vascular endothelium, which lies at
the interface between the blood and the tissue space, creates
a transport barrier for pharmacologic agents by blocking the
extravasation of any particulates larger than serum albumin
molecules (66 kDa)1. Delivery of large drug molecules and drug
carriers, including therapeutic proteins, nucleic acids and
nanomaterials, occurs either only at the level of the vascular
endothelium itself or when the permeability of the endothelial
barrier is signiﬁcantly increased. In this regard, current drug
delivery strategies are primarily aimed at treating solid tumours,
in which large pores are opened along the endothelium of
angiogenic vessels2,3. Nevertheless, the success of delivering
anticancer drugs is often impeded by the inherent heterogeneity
in vascular permeability due to the complex interplay between the
vessels and the tumour microenvironment4. In many other
diseases, such as cardiovascular diseases and central nervous
system diseases, the vascular endothelium maintains its structural
and functional integrity, preventing sufﬁcient drug delivery
into the tissue space. Circumventing endothelial barrier is,
therefore, the key for achieving an adequate, uniform and
targeted distribution of therapeutic agents in many critical
disease treatments.
Transport across the vascular endothelium can occur via either
transcellular or paracellular route. Both are tightly regulated
through a complex network of signalling pathways to maintain
the homeostasis of tissue microenvironment1. These transport
pathways have been utilized for developing efﬁcient biological
and biophysical delivery approaches. For example, antibodies
targeting aminopeptidase P can trigger caveolae-mediated
transcytosis in the lung endothelium, thus promoting cargo
transport from blood into lung tissue5. Infusion or superfusion
of vascular endothelial growth factor (VEGF) can increase
vascular permeability and promote transvascular transport of
macromolecules and nanoparticles into tumour tissue6,7. The
effect of VEGF on vascular permeability is partly attributed to its
regulation of endothelial junctional proteins that control
paracellular transport8. Alternatively, intracarotid infusion of
hyperosmotic agents or vessel dilators is used to transiently open
the blood–brain barrier by inducing endothelial cell shrinkage
and vascular dilatation9. These approaches, however, lack the
capability of targeting speciﬁc anatomic regions, which can lead
to non-speciﬁc drug uptake and consequential adverse off-target
effects. More recently, attempts have been made to use focused
ultrasound and circulating microbubbles to generate localized
enhancement of vascular permeability10,11. However, several
issues still remain to be addressed in this approach, including
tissue heating, attenuation of ultrasound by complex anatomical
structures and the rapid clearance of microbubbles by the
mononuclear phagocyte system12. There is, therefore, an
urgent need for a more efﬁcient target delivery approach in
many disease treatments.
Over the past few years, magnetic nanoparticles (MNPs) have
emerged as promising drug carriers in image-guided drug delivery,
magnetic drug delivery, and synergistic chemotherapy and
hyperthermia13–17. Extensive studies have been performed to
increase the internalization/accumulation of MNPs in vitro or
in vivo with an externally applied magnetic ﬁeld18–21. Moreover, as
nano-sized magnets, MNPs have been utilized to deliver
mechanical cues to living cells at the molecular level, which
provides an unprecedented capability for controlling cell signalling
pathways and intracellular events22–25. In our previous studies, we
have shown that magnetic force can enhance the endocytosis of
MNPs by various cell types including human umbilical vein
endothelial cells (HUVECs) without affecting cell viability20,21.
Also, in static culture, the magnetic force applied to intracellular
MNPs can modulate the F-actin dynamics and organization
in endothelial cells21. It is known that VE-cadherin, the key
component of endothelial adherens junctions that mediate the
paracellular transport across the vascular endothelium, anchors
to the actin cytoskeleton in integral endothelium, and this
association between VE-cadherin and F-actin tightly controls
endothelial barrier function26,27. Alterations in actin ﬁlament
organization induced by either actin-depolymerizing or -stabilizing
substances can disrupt adherens junctions and increase vascular
permeability28,29.
In this work, we investigate the intracellular magnetic
force-induced structural and functional changes of the vascular
endothelial barrier through in vitro studies using endothelialized
microﬂuidic channels, and in vivo experiments with a mouse
lateral tail vein model. We demonstrate that vascular permeability
in a tissue can be increased magnetically through a two-step
process using external magnets—targeting of MNPs to the
vascular endothelium and disrupting the endothelial adherens
junctions via intracellular magnetic forces from MNPs.
This approach provides a physically controlled drug delivery
method that opens a new avenue for drug delivery in a broad
range of biomedical research and therapeutic applications.
Results
MNPs and magnetic force. Both the magnetic properties
of MNPs and the applied magnetic ﬁeld are essential for targeted
cellular internalization of MNPs and exerting adequate intracel-
lular magnetic force. Here we synthesized magnetite nanocrystals
(16 and 33 nm in diameter) through thermo-decomposition of
iron acetylacetonate (Fig. 1a–c)30,31. Both nanocrystals exhibited
saturation magnetization approaching that of bulk magnetite but
little remanence at zero ﬁeld (Fig. 1d). Water-dispersible MNPs
were synthesized by coating the nanocrystals with phospholipid-
poly(ethylene glycol) (Fig. 1a, inset in Fig. 1b; Supplementary
Table 1)32. The phospholipid coating facilitated labelling MNPs
with DiI (ex/em¼ 549/565 nm) or DiR (ex/em¼ 710/780 nm) for
their visualization in vitro and in vivo, respectively (Fig. 1e;
Supplementary Figs 1 and 2).
The applied magnetic ﬁeld was created using NdFeB magnets
(see Methods section). The spatial distribution of the magnetic
ﬁeld was determined by numerical simulation (Supplementary
Methods; Supplementary Table 2; Supplementary Figs 3–5). The
ﬁeld strength is B5,000Oe on the surface of an NdFeB magnet.
Assuming a ﬁeld gradient of 100 Tm 1, the magnetic force on
individual MNPs is on the order of 1 fN and B900-fold higher
than the gravitational force (Fig. 1f).
We then examined the magnetic force-regulated MNPs uptake
and actin dynamics in static cell culture. As shown in Fig. 2a,b,
the magnetic ﬁeld markedly enhanced the uptake of MNPs
by endothelial cells. Intracellular MNPs accumulated primarily
in perinuclear lysosomes. The amount of intracellular MNPs
shows large variation among endothelial cells, owing to the
heterogeneous magnetic force ﬁeld used in cell culture (Fig. 2c;
Supplementary Fig. 3). On the basis of the iron content
measurement, these cells contained 5.8±0.7 105 MNPs per
cell (Fig. 2d). When the endothelial cells with MNPs were further
incubated at the edge of an NdFeB block magnet, the total
intracellular magnetic force parallel to the cell surface is on the
order of 2 10 10N. After 1 h incubation, randomly distributed
F-actin ﬁbres in endothelial cells became aligned in the direction
of the magnetic force (Fig. 2e,f). It is noteworthy that the
total intracellular magnetic force is similar to the shear force
experienced by the cells at a shear stress of 5 dyn cm 2, assuming
the surface area of an endothelial cell is 400 mm2. It suggests that
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the MNPs and the magnets used in this study can generate
an intracellular magnetic force with the same order of magnitude
compared to the shear force on the vascular endothelium in
capillaries and post-capillary venules at the surface of the body33.
Endothelialized microﬂuidic channels. Endothelial cells can
mechanosense the ﬂuid shear stress exerted on the cell membrane
and respond by organizing actin ﬁlaments along the ﬂow
direction34,35. The direction of the intracellular magnetic force
relative to the shear stress is, therefore, likely to affect the
organization and alignment of preformed actin ﬁlaments. We
constructed an endothelialized microﬂuidic system, which not
only provided a tightly controlled ﬂow environment mimicking
the physiologic hemodynamic conditions (1–10 dyn cm 2) in
blood vessels but also facilitated microscopic examination
of the endothelium (Fig. 3a,b)36,37. A conﬂuent monolayer of
endothelial cells covering the entire three-dimensional inner
surface of microﬂuidic channels was cultured under physiologic
ﬂow conditions (Fig. 3c,d; Supplementary Fig. 6). Similar to the
vascular endothelium in vivo38, F-actin ﬁbres in endothelial cells
were located near the cell–cell interface and aligned with the ﬂow
direction as well (Fig. 3e). Further, adherens junctions visualized
with VE-cadherin staining conﬁrmed the continuity of cell–cell
interface (Fig. 3f). In addition, the microﬂuidic platform with
a well-designed geometry enabled to better control the direction
of magnetic force relative to the shear stress and the preformed
F-actin ﬁbres.
Effects of intracellular magnetic force in vitro. To determine
the effects of magnetic force on the uptake of MNPs and the
organization and alignment of preformed actin ﬁlaments in
endothelial cells under ﬂow conditions, we placed an NdFeB
block magnet under the microﬂuidic device, with its magnetiza-
tion axis in the vertical direction (z axis) and its longitudinal
direction (x axis) aligned with the ﬂow direction in the
microﬂuidic channel (Fig. 4a–c). Due to the symmetry of mag-
netic ﬁeld in the x direction, MNPs in the microﬂuidic channel
only experience magnetic forces in the z and y directions: fz is
perpendicular to both the ﬂow direction and the bottom surface
of the channel and fy is perpendicular to the ﬂow direction but
tangential to the bottom surface. When the microﬂuidic channel
is placed along the midline of the magnet (setting I, Fig. 4d),
fz and fy are nearly uniform throughout the channel (Fig. 4b,c).
A numerical simulation indicates that for a 16 nm MNP at this
position, fz is 6.7 10 17N, while fy is negligible (Fig. 4b,c;
Supplementary Fig. 7). fz drives MNPs toward the endothelial
cells on the bottom surface of the channel. When the channel is
aligned with the edge of the magnet (setting II, see Fig. 4e), the
magnitude of fz increases to 8.6 10 16N and fy becomes
4.1 10 16N (Fig. 4b,c; Supplementary Fig. 7). To better
elucidate the effects of magnetic force on endothelial cells, these
two force settings were used for enhancing MNPs internalization
and applying a magnetic force to intracellular MNPs, respectively.
The uptake of MNPs (16 nm/DiI) by endothelial cells under
ﬂow (Vaverage¼ 0.46mm s 1) increased signiﬁcantly compared
with those cultured in static (Supplementary Fig. 8). However,
a further tenfold increase in the ﬂow velocity had no signiﬁcant
effect on the uptake rate, suggesting that cell internalization is the
rate-limiting step under ﬂow. With the external magnetic forces
at setting I, the uptake of MNPs under the ﬂow condition was
further increased by a factor of 2.3, and a larger amount of MNPs
was taken up by endothelial cells at the bottom of the channel
than at other locations (Fig. 4f; Supplementary Fig. 9). However,
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Figure 1 | Properties of magnetic iron oxide nanoparticles (MNPs). (a) A schematic diagram of MNP. Each MNP contains a magnetite nanocrystal and a
phospholipid–PEG coating. The phospholipid layer provides anchoring sites for lipophilic ﬂuorophores such as DiI or DiR for ﬂuorescence tracing of MNP.
(b,c) TEM images of 16 and 33 nm diameter magnetite nanocrystals. Inset in b shows phospholipid–PEG-coated MNPs negatively stained with
phosphotungstic acid. The phospholipid–PEG coating of MNPs appears as the white corona surrounding the dark nanocrystals. Scale bar, 100 nm.
(d) Magnetization curves of MNPs. (e) Absorption and emission spectra of 16 nm MNPs labelled with DiI (16 nm/DiI) and 33 nm MNPs labelled with DiR
(33 nm/DiR), respectively. (f) Calculated magnetic force on individual MNPs as a function of the ﬁeld strength. The gradient of the magnetic ﬂux density
was assumed to be 100Tm 1.
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fz alone did not cause any detectable change in actin ﬁlaments
(Supplementary Fig. 10).
In subsequent experiments, after endothelial cells in the
microﬂuidic channel were loaded with MNPs using setting I
(Fig. 4d, step I), the channels were incubated with setting II, where
MNPs experience forces in both the y direction (fy) and z direction
(fz) that are B3–4 orders of magnitude of the gravitational force
(Fig. 4e, step II). Here we found that after endothelial cells were
exposed to fy for 1 h, F-actin ﬁbres along the ﬂow direction were
reduced (Fig. 4g) as compared to the control condition in which no
magnetic force is applied (Fig. 3e). In addition, the distribution of
VE-cadherin became discontinuous and diffuse, indicating the
disruption of adherens junctions at intercellular interfaces (Fig. 4h).
Interestingly, after 12h incubation with ﬂow upon the withdrawal
of magnetic force, endothelial cells reformed F-actin ﬁbres along
the ﬂow direction and VE-cadherin returned to its original
distribution, that is, continuous and condensed between adjacent
cells (Fig. 4j,k). These data suggest that endothelial cells can
simultaneously mechanosense the ﬂow-induced shear stress and
the intracellular MNP-exerted force, and the relative direction of
these two forces modulates F-actin dynamics. Comparison between
Figs 3e and 4g,j indicates that the intracellular magnetic force was
large enough to induce a reversible change in actin cytoskeleton
and the changes in actin ﬁlaments led to a temporary disruption to
endothelial adherens junctions rather than permanent alterations to
endothelial function.
To examine whether the magnetic force-induced disruption of
the endothelial adherens junction alters the barrier function of the
endothelium, the endothelialized microﬂuidic channel subjected
to the magnetic treatment (step I and step II described above) was
infused with an antibody against collagen I immediately after
exposure to magnetic ﬁeld or after the endothelial channel
recovered overnight. The microﬂuidic channel was coated with
collagen I to support the growth of endothelial cells and thus
located at the basal side of the endothelium. An antibody
(B150 kD) is signiﬁcantly larger than a serum albumin molecule
(66 kD) and therefore cannot diffuse through intact endothelial
cell–cell junctions. We found that collagen I was positively
stained after the magnetic treatment, indicating that the
endothelial layer became permeable to the antibody (Fig. 4i). In
contrast, the anti-collagen staining was not detectable after
recovery of adherens junction (Fig. 4l). These results demonstrate
that the magnetic force-induced disruption of endothelial
adherens junctions caused the endothelial layer becoming
permeable to large protein molecules.
In vivo magnetic switch of vascular permeability. We further
tested the concept of magnetic control of vascular permeability
in vivo in a mouse lateral tail vein model in athymic nude mice.
MNPs were injected into the systemic circulation from the distal
end of a mouse lateral tail vein, and the opposite lateral tail vein
was placed along an NdFeB block magnet (Fig. 5a–c). Our initial
studies and computational numerical simulations showed that
magnetic targeting in the lateral tail vein required a higher ﬁeld
gradient and larger MNPs due to the increased venous blood
Fluorescence (a.u.)
Fo
rw
ar
d 
Sc
at
te
r
CTL/MNP/MNP+MF
e f
a
b
*
dc
LysosomeMNP Merged
1.6×107 80
60
40
20
0
1.2×107
8×106
4×106
102 103 104 105
M
N
P 
pe
r c
el
l (×
 10
4 )
106
0
MN
P
MN
P +
 M
F
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velocity and a longer distance from the vessel to the magnet
(Fig. 5d,e; Supplementary Figs 12–15). Efﬁcient magnetic
targeting was achieved using 33 nm MNPs with a higher magnetic
force of B5 10 15N at the edge of the magnet, as shown by
in vivo near-infrared ﬂuorescence imaging of MNPs in the mouse
tail (Fig. 5f). We further quantiﬁed the amount of MNPs in
the mouse tail using a superconducting quantum interference
device (SQUID), and found that the iron content in the tail
(62±37 mg g 1 dry tissue) that subjected to applied magnetic
ﬁeld was signiﬁcantly higher than that without (6.3±13.1 mg g 1
dry tissue). Histological examination showed that MNPs
accumulated primarily in the large veins and small venules but
not in the arterioles, presumably due to the higher arterial blood
ﬂow speed. It also indicated that MNPs were only located in the
endothelium, but not in the interstitial tissues in the in vivo
experiments (Supplementary Fig. 16). These results conﬁrm the
effective magnetic targeting of MNPs in the mouse tail.
Vascular permeability was evaluated in vivo by monitoring
the accumulation in mouse tail of circulating indocyanine
green (ICG), a small near-infrared ﬂuorophore used in clinical
examinations of vessel leakage in ophthalmic angiography39.
ICG signal is a reliable measure of the altered permeability
in vasculature, since ICG molecules in the plasma bind to
lipoproteins and protein-bound ICG extravasates from leaky
blood vessels but not the normal ones40. In this study, after the
mice were injected with unlabelled MNPs, the lateral tail vein was
placed on the magnet for 2 h. Following exposure to the magnetic
ﬁeld, the mice received a bolus injection of ICG through the tail
vein and the distribution of ICG was monitored via in vivo
imaging. The ﬂuorescence signal of ICG increased in the tail of
the mice subjected to the magnetic ﬁeld (Fig. 6a,b). Enhanced
ICG signals correlated well with the location of the magnet but
were not conﬁned to the lateral vein, suggesting that extravasation
also occurred from surrounding microvessels. In the control
mice without the magnetic ﬁeld, MNPs alone had no effect on
ICG distribution. Taken together, these results demonstrate that
an external magnetic ﬁeld can induce local accumulation of
MNPs in the target tissue and increase vascular permeability in
vessels within the area where a magnetic ﬁeld is applied, which
is likely due to intracellular magnetic force-induced disruption
of endothelial adherens junctions.
Discussion
Overcoming the endothelial barrier is paramount to the
treatment of many diseases. In particular, it is essential to the
development of new biological therapies that involve engineered
proteins, nucleic acids as well as multifunctional nanoparticles as
drug carriers. To date, the main rationale for delivering these
large pharmacological agents to the target tissue or cells is the
enhanced permeability and retention effects pertaining to tumour
tissue at an active growing phase. Otherwise, for large drug
molecules and drug carriers, their systemic delivery is limited to
cells in the circulatory system. Here we developed a new strategy
in which biocompatible MNPs combined with a well-designed
magnetic ﬁeld can provide an externally controllable mechanical
cue to activate the paracellular transport pathway of vascular
endothelium at the desired location20. The applied magnetic force
30
 µ
m
a b
c d
e
Flow
Seeded with
HUVECs 
z
y
x
f
x
y
Flow
Figure 3 | Engineered in vitro endothelialized microﬂuidic channels. (a) Macroscopic view of a PDMS microdevice ﬁlled with red food colour.
(b) CAD-based geometric pattern of the microﬂuidic system. The smallest channels in this pattern are 30mm in width, and the height of the channels after
fabrication is also 30 mm. (c) A schematic diagram showing the process of ‘endothelization’ of the microﬂuidic channel. The endothelialized channel is
maintained under constant, physiologic ﬂow conditions. (d) A representative confocal image of the cross-section of the smallest channel after endothelial
cells reach conﬂuency (blue, nuclei; green, actin). (e) In the engineered endothelium, F-actin ﬁbres (red) were localized at the cell–cell interface and
stress ﬁbres (red) are aligned with the ﬂow (blue, nuclei). (f) The engineered endothelium comprises continuous adherens junctions, as shown on
anti-VE-cadherin staining (green). Scale bar, 30mm.
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on endothelial cells is determined by the amount of intracellular
MNPs, their size and the applied magnetic ﬁeld. Previous studies
have shown that a focused magnetic ﬁeld gradient can be
generated at any location in the body41,42; whether these
gradients are sufﬁcient for magnetic capture or to generate the
forces described here will depend on the properties of the
nanoparticles, the ﬂow rate in the vessels and the gradient
generated at that point. In contrast to ultrasound-based methods,
magnetic ﬁelds are not attenuated by biological tissues, enabling
better control of targeted delivery into deep tissue. In addition,
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the pharmacokinetics and interactions of MNPs with the vascular
endothelium can be optimized by ﬁne-tuning nanocrystal
synthesis and surface modiﬁcation, owing to a large repertoire
of nanofabrication techniques.
There are two major aspects concerning the potential clinical
application of the method developed in this study. The ﬁrst is to
deliver MNPs to the targeted endothelium, of which magnetic
targeting is just one of the many ways. Other approaches include
conjugating targeting ligands or cell-penetrating peptides to
MNPs and direct injection (when permitted). The second is to
apply magnetic force to intracellular MNPs in vivo (in deep
tissue), possibly using a clinical-grade magnetic device in which
multiple magnets of different strengths can be placed on the
patient at speciﬁc anatomic sites to yield the optimal magnetic
ﬁeld strength and distribution to enhance delivery at the desired
location43,44. Magnetic enhancement of vascular permeability
thus has the potential to be applied to any tissue or organ of
interest, regardless of the pathophysiological state.
Endothelial mechanotransduction of the blood ﬂow-induced
shear stress plays a critical role in modulating vascular
homeostasis. Dysregulation of the mechanotransduction path-
ways can trigger pathogenesis of cardiovascular diseases,
especially atherosclerosis45. The effects of the shear stress
include modulation of the cytoskeleton, intercellular junctions
and vascular permeability46,47. In this scenario, the shear
force is exerted on the membrane of endothelial cells, and the
mechanosensing has been hypothesized to be initiated through
cell surface mechanotransducers, such as carbohydrate-rich
glycocalyx and mechanosensory complex comprising of platelet
endothelial cell adhesion molecule 1, VE-cadherin and VEGF
receptor 2 (refs 48,49). However, MNP-generated intracellular
forces are more ‘body-force’ like rather than surface forces,
and the mechanisms underlying magnetic force-induced
mechanosensing and mechanotransduction remain elusive. Our
study demonstrates that the force applied through intracellular
MNPs can trigger the reorganization of F-actin ﬁbres and disrupt
endothelial adherens junctions. The phenotypic changes induced
by the transient application of intracellular forces are found to be
similar to those induced by a rapid change in the shear stress.
Microscopic examination shows that the intracellular MNPs
accumulated in the lysosomes, which have certain association
with actin ﬁlaments50. Our results suggest that the MNP-induced
intracellular forces may serve as a new way to apply distributed
forces inside the cell, which can be transmitted directly to the
cytoskeleton. Therefore, MNPs combined with an externally
controllable magnetic ﬁeld provide a novel technique to
trigger mechanoresponses of cells and can potentially offer new
insights into mechanobiology.
Conventional drug delivery methods employ polymers or
nanoparticles as drug carriers, which are limited to therapeutic
agents with speciﬁc properties for conjugation, adsorption or
encapsulation. In contrast, our approach provides a means to
remotely alter the cytoskeletal organization of endothelial cells via
intracellular magnetic forces, thus enhancing focal vascular
permeability and opening the gate for extravasation of all
circulating agents. It, therefore, extends targeted delivery to the
vast majority of injectable therapeutic agents. It should also be
noted that disrupting endothelial cell–cell junctions may expose
cell surface proteins and basement membrane that are otherwise
inaccessible to the blood circulation, potentiating additional
molecular markers for targeted delivery.
In conclusion, we demonstrate that the permeability of vascular
endothelium can be increased using an external magnetic ﬁeld
to temporarily disrupt endothelial adherens junctions through
internalized iron oxide nanoparticles, thus activate the para-
cellular transport pathway and facilitate the local extravasation of
circulating substances. The magnetic control method developed
in this work has the potential to shift the paradigm of targeted
drug delivery by delivering therapeutic agents to speciﬁc
anatomic regions within the body for a broad range of disease
interventions.
Methods
The investigators were not blinded to allocation during experiments and outcome
assessment.
Materials. Iron(III) acetylacetonate (99.9%), ICG and ﬁbronectin from human
plasma were purchased from Sigma-Aldrich. 1,2-Distearoyl-sn-glycero-3-phos-
phoethanolamine-N-[methoxy (polyethylene glycol)-2000] (ammonium salt)
(phospholipid–PEG) was purchased from Avanti Polar Lipids. 1,10-dioctadecyl-
3,3,30 ,30-tetramethylindocarbocyanine perchlorate (DiI) and 1,10-dioctadecyl-
3,3,30 ,30-tetramethylindotricarbocyanine iodide (DiR) were purchased from
Thermo Fisher Scientiﬁc. HUVECs from Lonza were cultured with EGM-2
medium purchased from Lonza. These cells were tested for mycoplasma
contamination and authenticated by the vendor.
Synthesis of magneto-ﬂuorescence nanoparticles. Magnetite nanocrystals were
synthesized by thermo-decomposition of iron acetylacetonate30,31. Transmission
electron microscopy (TEM) images of nanocrystals were recorded with a Hitachi
H-7500 Transmission Electron Microscope connected to a charge-coupled
device camera. The negative staining and TEM procedures were conducted by
Robert P. Apkarian Integrated Electron Microscopy Core at Emory University. The
size of the nanocrystals was measured as the average size of 4200 particles with
ImagePro Plus in TEM images. The magnetization of the nanocrystals was
measured with a SQUID (MPMS-XL, Quantum Design) at the Advanced Materials
Research Institute in the University of New Orleans. Water-dispersible MNPs were
generated by coating the nanocrystals with amphiphilic phospholipid–PEG
copolymers using a dual solvent exchange method32. MNPs were labelled with
ﬂuorophores by mixing MNPs and DiI or DiR in deionized water at a weight ratio
of 40:1 and incubating at ambient temperature for 12 h. Unbound ﬂuorophores
were removed by passing the solution through 0.2 mm syringe ﬁlters with HT
Tuffryn membrane. The size distribution and the zeta potential of the MNPs were
measured with the Mo¨biuz Zeta Potential and DLS Detector (Wyatt).
To demonstrate the ﬂuorescent signal is proportional to the iron centration, we
measured the ﬂuorescent signals of iron oxide solution at different concentrations
with a ﬂuorometer (Supplementary Fig. 1a). To further conﬁrm the ﬂuorescent dye
tightly binds to MNPs as a reliable marker, we ﬁrst incubated ﬂuorescent
dye-labelled MNPs with bovine serum albumin for 24 h, and analysed whether the
ﬂuorescent signals transferred to BSA using size exclusion chromatography (SEC)
analysis (Supplementary Fig. 1b). We then tested whether the ﬂuorescent tags
would detach from MNPs and transfer to cells when MNPs are in close contact
with the cell membrane due to magnetic force. This was performed at 4 oC to
completely inhibit cellular endocytosis and only allow the magnetic force to
mediate contact between MNPs and cell membrane (Supplementary Fig. 2).
Design of magnetic force ﬁelds. In this study, all magnetic ﬁelds were created
using NdFeB rare-earth magnets. Note that the magnetic force exerted on MNPs is
determined by the strength and gradient of the magnetic ﬁeld (Supplementary
Methods). As shown in Table 1, different assemblies of magnets were used to
generate force ﬁelds that could cover the cells in the desired range. In the cellular
uptake study, the cells were cultured in a chamber glass placed on top of an array of
cylindrical magnets covering the entire chamber. In all other studies, one or two
block magnets were used.
Effects of magnetic force on static cell culture in vitro. Lab-Tek two-well
chambered coverglass was coated with rat tail collagen type I solution at
0.1mgml 1. HUVECs were seeded onto the coverglass at a density of 1 105 cells
per well. After 24 h, the cells were incubated with MNPs at a concentration of 50 mg
of Fe per ml for 2 h. For magnetically enhanced cellular uptake, the coverglass was
placed on an array of NdFeB cylindrical magnets. After incubation, the cells were
washed with PBS and detached by treatment with trypsin-EDTA. The ﬂuorescence
Table 1 | The properties of magnets used in in vitro and
in vivo experiments.
Experiment Dimension of magnet Residue induction (T)
In vitro static cell culture
Cellular uptake Cylinder (d l¼ 1/1000  1/400) 1.32
Magnetic pulling Block (lw h¼ 100  1/400  1/400) 1.48
Microﬂuidic channels Block (lw h¼ 100  1/200  1/200) 1.48
In vivo lateral tail vein Block (lw h¼ 100  1/400  1/400) 1.48
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intensity of intracellular MNPs was quantiﬁed by ﬂow cytometry. To measure
the iron content of MNPs in the cells, the cells were counted and centrifuged.
After the cell pellets were dried under vacuum, the cells were digested with 12M
hydrochloric acid at 37 C for 1 h. The iron content was quantiﬁed using
a ferrozine assay. The iron content in each MNP was calculated using the size of
the nanocrystals determined in TEM with the assumption that the nanocrystals
consisted of pure magnetite51.
To study the effects of intracellular magnetic force on the cytoskeleton, the
cells were loaded with MNPs, detached and seeded in a new chamber glass.
After the cells were cultured overnight, the chamber was incubated on an
NdFeB block magnet for 2 h. At the end of experiments, the cells were ﬁxed
with 4% paraformaldehyde in PBS and the actin ﬁbres were stained with
phalloidin-alexa ﬂuor 488 (1:20; Life Technologies).
Fabrication of endothelialized microﬂuidic channels. To fabricate the
microﬂuidic devices, a top polydimethylsiloxane (PDMS) piece with microﬂuidic
channel features was fabricated using standard photolithography and soft
lithography. After activated with oxygen plasma, the PDMS layer was covalently
bonded onto a piece of coverglass. The microﬂuidic channels were ﬁrst coated with
a rat tail collagen type I solution at 1mgml 1 for 1 h, followed by coating with
human ﬁbronectin solution at 20 mgml 1 for another 1 h. HUVECs (passage 5–8)
were seeded into the microﬂuidic channels at a concentration ofB5 106 cells per
ml. After incubated at 37 C for 3 h, the microﬂuidic device was connected to a ﬂow
pump ﬁlled with cell culture medium (EGM-2, Lonza). The wall shear stress in the
smallest channels was set to designated values by adjusting the ﬂow rate. The
endothelial cells were cultured under ﬂow for 2–3 days before experiments.
Effects of magnetic force in microﬂuidic channels. MNPs were diluted to 50mg
of Fe per ml using EGM-2 medium and infused through the endothelialized
microﬂuidic channels with/without a magnet placed underneath the channels
(the detailed simulation of the magnetic ﬁeld and magnetic force in the channel
were provided in the Supplementary Materials). To elucidate the effect of ﬂow on
MNP uptake by endothelial cells, MNPs were infused into the endothelialized
microﬂuidic channels with a shear stress varying from 0 to 10 dyn cm 2 for 2 h. At
the end of experiments, 4% paraformaldehyde in PBS was infused through the
channels to ﬁx the cells. The z-stack confocal images of endocytosed MNPs were
taken, and the ﬂuorescence intensity was quantiﬁed using Image J on the
three-dimensional rendering images. To study the role of magnetic forces in MNP
uptake by endothelial cells and endothelial barrier function, MNPs were ﬁrst
infused into the endothelialized microﬂuidic channels with the channels placed
along the midline of the magnet (setting I, Fig. 4d) with a shear stress of
B6.5 dyn cm 2 for 2 h. After that, the endothelialized microﬂuidic channels were
aligned with the edge of the magnet and infused with cell culture medium only for
1 h (setting II, Fig. 4e). To study whether the disruption of adherens junctions is
reversible, the endothelialized microﬂuidic channels were further cultured with a
shear stress ofB6.5 dyn cm 2 for 12 h. To stain VE-cadherin, the endothelialized
channels were ﬁxed with 4% paraformaldehyde, washed with PBS, and blocked
in PBS containing 1% BSA, followed by perfusing with mouse anti-human
VE-cadherin (1:100, Santa Cruz, cat#: sc-9989) for 2 h. Then, the channels were
incubated with antibody at 4 C for 12 h. After ﬂushed with PBS containing
1% BSA, the channels were perfused with rabbit anti-mouse Alexa Fluor 488
(1:100, Life Technologies, cat#: A11001) in 1% BSA for 2 h. After further
washes with PBS, the channels were perfused with hoescht 33342 (1:1,000; Life
Technologies) and phalloidin-AF 647 (1:20; Life Technologies) for 1 h. Collagen I
in the microﬂuidic channels were stained with a monoclonal mouse anti-collagen
I antibody (Abcam, cat#: ab90395) using the same procedure.
In vivo permeability study. All animal procedures were approved by the
Institutional Animal Care and Use Committee at Rice University. Athymic nude
mice (Crl: NU(NCr)-Foxn1nu) were purchased from Charles River Laboratories.
Age-matched (4–5 weeks) female animals were randomly assigned to experimental
groups throughout all experiments. In the magnetic targeting experiment, 33 nm
MNPs labelled with DiR were diluted to 1mg of Fe per ml 1 with water. The
osmotic pressure of the solution was adjusted with dextrose. The mice were
anaesthetized with isoﬂurane. A measure of 0.15ml of MNPs was injected through
the distal end of a lateral tail vein. The mouse tail was taped onto the magnets to
align the contralateral tail vein with the edge of the magnet (Fig. 5a). After 2 h,
ﬂuorescence images of live mice were acquired with IVIS spectrum imaging station
(ex/em¼ 710 nm/780 nm). To quantify MNPs accumulated in the tail, the mice
were killed and infused with 10ml of PBS to remove circulating MNPs. Then, the
tails were dissected and cut into 10mm segments and dried under vacuum
overnight. The magnetization of the tissue was measured at 10,000Oe with SQUID
(MPMS, Quantum Design). Untreated mouse tails were used as the reference. The
iron content of MNPs was calculated by dividing the net magnetization of the
tissue by the magnetization of MNPs.
In the vascular permeability study, 0.15ml of unlabelled 33 nm MNPs was
injected through the distal end of a lateral tail vein. The contralateral tail vein was
treated with magnets for 2 h. After that, 0.05ml of ICG (2mgml 1 in water with
dextrose) was injected. Fluorescence images of live mice were acquired with IVIS
spectrum imaging station at 1 h after ICG injection (ex/em¼ 710 nm/810 nm).
Statistics. All results are expressed as the mean±s.d. Biological replicates were
used in all experiments. Data were analysed using the Student’s t-tests or one-way
analysis of varience with Dunnett’s post hoc test. The threshold for statistical
signiﬁcance was Po0.05. GraphPad Prism (GraphPad Software) was used for all
the calculations. No statistical methods were used to pre-determine the sample size
of the experiments.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding authors upon reasonable request.
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